Oncology & Cancer

Programming the immune system to supercharge cancer cell therapies

The first FDA-approved gene therapies are living drugs: immune cells taken from cancer patients engineered to target tumor cells. However, for many patients, these advanced therapies do not result in a long-lasting remission. ...

HIV & AIDS

Molecular structure reveals how HIV infects cells

In a long-awaited finding, a team of Chinese and US scientists has determined the high-resolution atomic structure of a cell-surface receptor that most strains of HIV use to get into human immune cells. The researchers also ...

Oncology & Cancer

Pushing T cells down 'memory lane' may improve cancer therapy

Scientists at St. Jude Children's Research Hospital identified a molecular mechanism that in a preclinical study unlocked the promise of CAR T-cell therapy for treatment of solid tumors. The results were published today in ...

Immunology

Receptor may hold key to multiple sclerosis treatment

(Medical Xpress) -- A receptor recently discovered to control the movement of immune cells across central nervous system barriers (including the blood-brain barrier) may hold the key to treating multiple sclerosis (MS), a ...

Alzheimer's disease & dementia

Study takes next step toward treatment for Alzheimer's disease

To date, scientists have identified 32 genetic mutations associated with an increased risk of Alzheimer's disease, with BYU contributing to many of those discoveries. Finding those links is important foundational research, ...

page 9 from 38